Physician profile
Maen Assali
NPI 1891215596
$6,545.69
in general payments reported to CMS, 2019-2025
18 companies · $473 in 2025
The $473 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $148 · 2022: $123 · 2023: $2,018 · 2024: $3,784 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,768 · Food and Beverage: $2,151 · Education: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,767.95 |
| Food and Beverage | $2,151.44 |
| Education | $355.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,786.50 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $1,785.60 | 2021-2024 | Mitraclip, Ensite, Cardiomems |
| Medtronic, INC. | $1,060.94 | 2024 | Corevalve Evolut R |
| Penumbra, INC. | $217.41 | 2023-2024 | Indigo System, Penumbra System |
| Chiesi USA, INC. | $185.41 | 2023-2025 | Kengreal, Cleviprex |
| Abiomed | $123.18 | 2023 | Impella |
| Philips North America LLC | $75.82 | 2025 | Igt Devices Undivided |
| Novartis Pharmaceuticals Corporation | $51.28 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $48.25 | 2024-2025 | Lifevest |
| Cardiva Medical, INC. | $36.73 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.09 | 2025 | Jardiance |
| Teleflex LLC | $27.84 | 2025 | Guideliner |
| Boston Scientific Corporation | $23.65 | 2023 | Sq-Rx Pulse Generator |
| Inspire Medical Systems, INC. | $21.91 | 2025 | Inspire |
| Shockwave Medical, INC | $21.01 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $16.06 | 2025 | Tyvaso |
| Pfizer INC. | $14.06 | 2025 | |
| Angiodynamics, INC. | $13.95 | 2025 | Alphavac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maen Assali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.